A molecular mechanism for the effect of lithium on development.
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Lithium, one of the most effective drugs for the treatment of bipolar (manic-depressive) disorder, also has dramatic effects on morphogenesis in the early development of numerous organisms. How lithium exerts these diverse effects is unclear, but the favored hypothesis is that lithium acts through inhibition of inositol monophosphatase (IMPase). We show here that complete inhibition of IMPase has no effect on the morphogenesis of Xenopus embryos and present a different hypothesis to explain the broad action of lithium. Our results suggest that lithium acts through inhibition of glycogen synthase kinase-3 beta (GSK-3 beta), which regulates cell fate determination in diverse organisms including Dictyostelium, Drosophila, and Xenopus. Lithium potently inhibits GSK-3 beta activity (Ki = 2 mM), but is not a general inhibitor of other protein kinases. In support of this hypothesis, lithium treatment phenocopies loss of GSK-3 beta function in Xenopus and Dictyostelium. These observations help explain the effect of lithium on cell-fate determination and could provide insights into the pathogenesis and treatment of bipolar disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Berridge, M. J., Dawson, R. M. C., Downes, C. P., Heslop, J. P., & Irvine, R. F. (1983) · Biochemical Journal · doi:10.1042/bj2120473 · Cited by 1,954
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Hallcher, L. M., & Sherman, W. R. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70391-3 · Cited by 1,101
Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4
Stark, K., Vainio, S., Vassileva, G., & McMahon, A. P. (1994) · Nature · doi:10.1038/372679a0 · Cited by 1,071
Neural and developmental actions of lithium: A unifying hypothesis
Berridge, M. J., Downes, C. P., & Hanley, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90026-3 · Cited by 1,014
Sutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903
Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., & Anderton, B. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90774-2 · Cited by 737
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15
Nusse, R., van Ooyen, A., Cox, D., Fung, Y. K. T., & Varmus, H. (1984) · Nature · doi:10.1038/307131a0 · Cited by 612
McMahon, A. P., & Moon, R. T. (1989) · Cell · doi:10.1016/0092-8674(89)90506-0 · Cited by 529
Cited by
Items 101–200 of 268
Cross, D. A. E., Culbert, A. A., Chalmers, K. A., Facci, L., Skaper, S. D., & Reith, A. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00251.x · Cited by 377
Tong, H., Imahashi, K., Steenbergen, C., & Murphy, E. (2002) · Circulation Research · doi:10.1161/01.res.0000012567.95445.55 · Cited by 376
Paullones are potent inhibitors of glycogen synthase kinase‐3β and cyclin‐dependent kinase 5/p25
Leost, M., Schultz, C., Link, A., Wu, Y., Biernat, J., Mandelkow, E., Bibb, J. A., Snyder, G. L., Greengard, P., Zaharevitz, D. W., et al. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01673.x · Cited by 376
Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 375
A Role for Glycogen Synthase Kinase-3β in the Mammalian Circadian Clock
Iitaka, C., Miyazaki, K., Akaike, T., & Ishida, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503526200 · Cited by 373
Machado‐Vieira, R., Manji, H. K., & Zarate Jr, C. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00714.x · Cited by 370
Nuttall, M. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.002 · Cited by 370
Yamamoto, H., Kishida, S., Kishida, M., Ikeda, S., Takada, S., & Kikuchi, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10681 · Cited by 364
Role of GSK3β in behavioral abnormalities induced by serotonin deficiency
Beaulieu, J.-M., Zhang, X., Rodriguiz, R. M., Sotnikova, T. D., Cools, M. J., Wetsel, W. C., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711496105 · Cited by 368
Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder
Nunes, P. V., Forlenza, O. V., & Gattaz, W. F. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.029868 · Cited by 368
Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., Scott, C. W., & Lee, C.-M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190297597 · Cited by 366
Multisite Phosphorylation by Cdk2 and GSK3 Controls Cyclin E Degradation
Welcker, M., Singer, J., Loeb, K. R., Grim, J., Bloecher, A., Gurien-West, M., Clurman, B. E., & Roberts, J. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00287-9 · Cited by 363
Cyclic AMP Promotes Neuronal Survival by Phosphorylation of Glycogen Synthase Kinase 3β
Li, M., Wang, X., Meintzer, M. K., Laessig, T., Birnbaum, M. J., & Heidenreich, K. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9356-9363.2000 · Cited by 363
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
Beaulieu, J.-M., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2008) · Cell · doi:10.1016/j.cell.2007.11.041 · Cited by 362
Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments
Coyle, J. T., & Duman, R. S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00195-8 · Cited by 360
GSK3 and tau: Two convergence points in Alzheimer’s disease
Hernandez, F., Lucas, J. J., & Avila, J. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129025 · Cited by 359
Yasuda, S., Liang, M.-H., Marinova, Z., Yahyavi, A., & Chuang, D.-M. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002099 · Cited by 358
The Wnt/Wg Signal Transducer β-Catenin Controls Fibronectin Expression
Gradl, D., Kühl, M., & Wedlich, D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5576 · Cited by 355
Guo, Z., & Sadler, P. J. (1999) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(08)60271-8 · Cited by 354
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
Eldar-Finkelman, H., & Martinez, A. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00032 · Cited by 354
Willert, K., & Nusse, R. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007864 · Cited by 353
Manji, H. K., Moore, G. J., & Chen, G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00979-3 · Cited by 352
WNT Signaling in Cardiac and Vascular Disease
Foulquier, S., Daskalopoulos, E. P., Lluri, G., Hermans, K. C. M., Deb, A., & Blankesteijn, W. M. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.013896 · Cited by 347
Expression Profiling and Functional Analysis of Wnt Signaling Mechanisms in Mesenchymal Stem Cells
Etheridge, S. L., Spencer, G. J., Heath, D. J., & Genever, P. G. (2004) · STEM CELLS · doi:10.1634/stemcells.22-5-849 · Cited by 344
Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A., & Steckler, T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5216-05.2006 · Cited by 341
“The role of GSK-3-mediated signaling in the pathophysiology of bipolar disorder received special attention over recent years, in particular because of the effects of lithium on GSK-3 activity (Klein and Melton, 1996; Beaulieu et al., 2004; Gould et al., 2004b).”
BackgroundThe Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation
Plattner, F., Angelo, M., & Giese, K. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603469200 · Cited by 340
Neuroplasticity and cellular resilience in mood disorders
Manji, H. K., Moore, G. J., Rajkowska, G., & Chen, G. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000811 · Cited by 340
Wnt-induced dephosphorylation of Axin releases beta -catenin from the Axin complex
Willert, K., Shibamoto, S., & Nusse, R. (1999) · Genes & Development · doi:10.1101/gad.13.14.1768 · Cited by 338
Diehn, M., Alizadeh, A. A., Rando, O. J., Liu, C. L., Stankunas, K., Botstein, D., Crabtree, G. R., & Brown, P. O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092284399 · Cited by 337
Control of β-Catenin Stability
Salic, A., Lee, E., Mayer, L., & Kirschner, M. W. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80446-3 · Cited by 335
Spencer, G. J., Utting, J. C., Etheridge, S. L., Arnett, T. R., & Genever, P. G. (2006) · Journal of Cell Science · doi:10.1242/jcs.02883 · Cited by 334
Martinez, A., Castro, A., Dorronsoro, I., & Alonso, M. (2002) · Medicinal Research Reviews · doi:10.1002/med.10011 · Cited by 333
De Ferrari, G. V., Chacón, M. A., Barría, M. I., Garrido, J. L., Godoy, J. A., Olivares, G., Reyes, A. E., Alvarez, A., Bronfman, M., & Inestrosa, N. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001208 · Cited by 332
Forlenza, O. V., De-Paula, V. J. R., & Diniz, B. S. O. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000309 · Cited by 332
Sleire, L., Førde, H. E., Netland, I. A., Leiss, L., Skeie, B. S., & Enger, P. Ø. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.07.013 · Cited by 329
“Its effects on cancer cells have largely been attributed to the inhibition of glycogen synthase kinase 3, which again impacts on multiple cellular functions (150).”
BackgroundGBP, an Inhibitor of GSK-3, Is Implicated in Xenopus Development and Oncogenesis
Yost, C., Farr, G. H., Pierce, S. B., Ferkey, D. M., Chen, M. M., & Kimelman, D. (1998) · Cell · doi:10.1016/s0092-8674(00)81208-8 · Cited by 328
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
An ancient role for nuclear β-catenin in the evolution of axial polarity and germ layer segregation
Wikramanayake, A. H., Hong, M., Lee, P. N., Pang, K., Byrum, C. A., Bince, J. M., Xu, R., & Martindale, M. Q. (2003) · Nature · doi:10.1038/nature02113 · Cited by 324
Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons
Muñoz-Montaño, J. R., Moreno, F. J., Avila, J., & Dı́az-Nido, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00688-1 · Cited by 322
Desbois-Mouthon, C., Cadoret, A., Blivet-Van Eggelpoël, M.-J., Bertrand, F., Cherqui, G., Perret, C., & Capeau, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204064 · Cited by 321
“Consistent with this, treatment with lithium chloride (LiCl), a pharmacological agent well-known for its inhibitory e ect on GSK-3b activity (Klein and Melton, 1996; Stambolic et al., 1996), increased reporter activity (Figure 3b).”
BackgroundGould, T. D., Einat, H., Bhat, R., & Manji, H. K. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004535 · Cited by 314
Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
Manji, H. K., Moore, G. J., & Chen, G. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00165-1 · Cited by 313
Moon, R. T., & Kimelman, D. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199807)20:7<536::aid-bies4>3.0.co;2-i · Cited by 313
T cell anergy and costimulation
Appleman, L. J., & Boussiotis, V. A. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00009.x · Cited by 305
Distinct roles for Fgf, Wnt and retinoic acid in posteriorizing the neural ectoderm
Kudoh, T., Wilson, S. W., & Dawid, I. B. (2002) · Development · doi:10.1242/dev.129.18.4335 · Cited by 302
Glycogen Synthase Kinase-3β Facilitates Staurosporine- and Heat Shock-induced Apoptosis
Bijur, G. N., De Sarno, P., & Jope, R. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7583 · Cited by 301
Lucas, F. R., Goold, R. G., Gordon-Weeks, P. R., & Salinas, P. C. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.10.1351 · Cited by 301
Evidence that Fold-Change, and Not Absolute Level, of β-Catenin Dictates Wnt Signaling
Goentoro, L., & Kirschner, M. W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.11.017 · Cited by 300
In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain
Li, X., Zhu, W., Roh, M.-S., Friedman, A. B., Rosborough, K., & Jope, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300439 · Cited by 300
“…much attention from investigators studying mood disorders because the mood stabilizer lithium was found to be a direct inhibitor of GSK3β, a finding that raised the possibility that GSK3β may not be adequately controlled in mood disorders (Klein and Melton, 1996;Phiel and Klein, 2001;Jope, 2003).”
BackgroundActivity-dependent synaptic Wnt release regulates hippocampal long term potentiation
Chen, J., Park, C. S., & Tang, S.-J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511920200 · Cited by 298
Targeting protein kinases in central nervous system disorders
Chico, L. K., Van Eldik, L. J., & Watterson, D. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2999 · Cited by 298
Su, Y., Ryder, J., Li, B., Wu, X., Fox, N., Solenberg, P., Brune, K., Paul, S., Zhou, Y., Liu, F., et al. (2004) · Biochemistry · doi:10.1021/bi035627j · Cited by 296
Karner, C. M., Das, A., Ma, Z., Self, M., Chen, C., Lum, L., Oliver, G., & Carroll, T. J. (2011) · Development · doi:10.1242/dev.057646 · Cited by 295
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
Li, X., & Jope, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.105 · Cited by 294
“The first evidence that GSK3 may be involved in mood disorders emerged from two reports showing that the classical mood stabilizer lithium is a direct inhibitor of GSK3 (Klein and Melton, 1996; Stambolic et al, 1996) by a magnesiumcompetitive mechanism (Ryves and Harwood, 2001).”
Toledo, E. M., & Inestrosa, N. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.72 · Cited by 293
Selderslaghs, I. W. T., Van Rompay, A. R., De Coen, W., & Witters, H. E. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.05.004 · Cited by 292
Wnt signaling function in Alzheimer’s disease
De Ferrari and, G. V., & Inestrosa, N. C. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00021-7 · Cited by 289
Beurel, E., Song, L., & Jope, R. S. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.47 · Cited by 288
Shaggy/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus
Jia, J., Amanai, K., Wang, G., Tang, J., Wang, B., & Jiang, J. (2002) · Nature · doi:10.1038/nature733 · Cited by 288
“In contrast, wing discs overexpressing mCa or Cos2 accumulate high levels of Ci155 after treatment with 50 mM LiCl, a specific inhibitor of GSK3 kinase activit”
BackgroundRockenstein, E., Torrance, M., Adame, A., Mante, M., Bar-on, P., Rose, J. B., Crews, L., & Masliah, E. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4321-06.2007 · Cited by 288
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Browne, C. A., & Lucki, I. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00161 · Cited by 285
“GLYCOGEN SYNTHASE KINASE-3 (GSK-3) GSK-3 is a serine/threonine protein kinase and a major target for the mood stabilizer lithium (Klein and Melton, 1996; Stambolic et al., 1996).”
BackgroundCohen, E. D., Wang, Z., Lepore, J. J., Lu, M. M., Taketo, M. M., Epstein, D. J., & Morrisey, E. E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31731 · Cited by 282
A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun
Morton, S. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg388 · Cited by 281
Goold, R. G., Owen, R., & Gordon-Weeks, P. R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.19.3373 · Cited by 281
Otto, A., Schmidt, C., Luke, G., Allen, S., Valasek, P., Muntoni, F., Lawrence-Watt, D., & Patel, K. (2008) · Journal of Cell Science · doi:10.1242/jcs.026534 · Cited by 280
Wikramanayake, A. H., Huang, L., & Klein, W. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9343 · Cited by 279
Judging a Protein by More Than Its Name: GSK-3
Woodgett, J. R. (2001) · Science's STKE · doi:10.1126/stke.2001.100.re12 · Cited by 279
Kaidanovich-Beilin, O., Milman, A., Weizman, A., Pick, C. G., & Eldar-Finkelman, H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.008 · Cited by 276
Effects of Wnt Signaling on Proliferation and Differentiation of Human Mesenchymal Stem Cells
de Boer, J., Wang, H. J., & van Blitterswijk, C. (2004) · Tissue Engineering · doi:10.1089/107632704323061753 · Cited by 275
Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder
Zarate, C. A., Singh, J., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.021 · Cited by 274
WNT-7a Induces Axonal Remodeling and Increases Synapsin I Levels in Cerebellar Neurons
Lucas, F. R., & Salinas, P. C. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8734 · Cited by 274
The Polycystic Kidney Disease 1 Gene Product Modulates Wnt Signaling
Kim, E., Arnould, T., Sellin, L. K., Benzing, T., Fan, M. J., Grüning, W., Sokol, S. Y., Drummond, I., & Walz, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4947 · Cited by 271
Glycogen Synthase Kinase-3β Modulates Notch Signaling and Stability
Foltz, D. R., Santiago, M. C., Berechid, B. E., & Nye, J. S. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00888-6 · Cited by 271
Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration
Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Avila, J., Bogónez, E., & Dı́az-Nido, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00685-7 · Cited by 270
Inhibition of GSK3 by lithium, from single molecules to signaling networks
Freland, L., & Beaulieu, J.-M. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00014 · Cited by 269
GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer
Lin, J., Song, T., Li, C., & Mao, W. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118659 · Cited by 268
Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities
Huang, P., Yan, R., Zhang, X., Wang, L., Ke, X., & Qu, Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.008 · Cited by 268
Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer
Chen, C.-Y., Jan, Y.-H., Juan, Y.-H., Yang, C.-J., Huang, M.-S., Yu, C.-J., Yang, P.-C., Hsiao, M., Hsu, T.-L., & Wong, C.-H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220425110 · Cited by 266
Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage
Watcharasit, P., Bijur, G. N., Zmijewski, J. W., Song, L., Zmijewska, A., Chen, X., Johnson, G. V. W., & Jope, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122062299 · Cited by 266
GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila
Mudher, A., Shepherd, D., Newman, T. A., Mildren, P., Jukes, J. P., Squire, A., Mears, A., Berg, S., MacKay, D., Asuni, A. A., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001483 · Cited by 265
Heisenberg, C.-P., Houart, C., Take-uchi, M., Rauch, G.-J., Young, N., Coutinho, P., Masai, I., Caneparo, L., Concha, M. L., Geisler, R., et al. (2001) · Genes & Development · doi:10.1101/gad.194301 · Cited by 265
Endophenotypes in bipolar disorder
Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264
The role of GSK‐3 in synaptic plasticity
Peineau, S., Bradley, C., Taghibiglou, C., Doherty, A., Bortolotto, Z. A., Wang, Y. T., & Collingridge, G. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.2 · Cited by 263
Glycogen Synthase Kinase-3β (GSK3β) Binds to and Promotes the Actions of p53
Watcharasit, P., Bijur, G. N., Song, L., Zhu, J., Chen, X., & Jope, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305870200 · Cited by 262
Zhou, B., Liu, Y., Kahn, M., Ann, D. K., Han, A., Wang, H., Nguyen, C., Flodby, P., Zhong, Q., Krishnaveni, M. S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276311 · Cited by 261
Engel, T., Hernández, F., Avila, J., & Lucas, J. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0604-06.2006 · Cited by 260
Shi, S.-H., Cheng, T., Jan, L. Y., & Jan, Y.-N. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.009 · Cited by 259
Cheesman, S. E., Neal, J. T., Mittge, E., Seredick, B. M., & Guillemin, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000072107 · Cited by 258
Song, L., De Sarno, P., & Jope, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206047200 · Cited by 256
Kotliarova, S., Pastorino, S., Kovell, L. C., Kotliarov, Y., Song, H., Zhang, W., Bailey, R., Maric, D., Zenklusen, J. C., Lee, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0850 · Cited by 254
Manji, H. K., & Lenox, R. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00235-8 · Cited by 241
Yuskaitis, C. J., & Jope, R. S. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.014 · Cited by 240
Lazarus, J. H. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.002 · Cited by 230
5-HT1A receptor-regulated signal transduction pathways in brain
Polter, A. M., & Li, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.019 · Cited by 225
Polter, A., Beurel, E., Yang, S., Garner, R., Song, L., Miller, C. A., Sweatt, J. D., McMahon, L., Bartolucci, A. A., Li, X., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.43 · Cited by 225
“GSK3 has been suspected of contributing to bipolar disorder since the discovery that lithium, an effective mood stabilizer used therapeutically for bipolar disorder, is a selective inhibitor of GSK3 (Klein and Melton, 1996; Stambolic et al, 1996).”
BackgroundEngel, T., Goñi‐Oliver, P., Lucas, J. J., Avila, J., & Hernández, F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04139.x · Cited by 223
Yildiz, A., Guleryuz, S., Ankerst, D. P., Öngür, D., & Renshaw, P. F. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.43 · Cited by 213
“of episodes/subject, median (range)b Total 4 (1-42) 3 (1-41) .”
Cellular Circadian Clocks in Mood Disorders
McCarthy, M. J., & Welsh, D. K. (2012) · Journal of Biological Rhythms · doi:10.1177/0748730412456367 · Cited by 203
“Lithium inhibits GSK3β (Klein and Melton, 1996), which phosphorylates the clock components BMAL1 (Sahar et al., 2010), CRY2 (Harada et al., 2005), PER2 (Iitaka et al., 2005), and REV-ERBα (Yin, 2006).”
BackgroundPharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans
McColl, G., Killilea, D. W., Hubbard, A. E., Vantipalli, M. C., Melov, S., & Lithgow, G. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705028200 · Cited by 202
Nikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Carter, L., Johnson, K., & Henry, R. R. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2190 · Cited by 198
Metadata
- Authors
- Klein, P. S., & Melton, D. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-08-06
- Volume
- 93
- Issue
- 16
- Pages
- 8455-8459
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2051788298
- Cited by
- 2,301
- References
- 37
- FWCI
- 15.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.